SCHEMBL4358729

SCHEMBL4358729

O=C(NSc1cccc(OCc2ccccc2)c1)NC(=O)c1cc2cc(-c3ccccc3)ccc2o1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ANO1 Q5XXA6 3/20 0.44
SMPD1 P17405 2/20 0.44
MAOB P27338 1/20 0.43
PTPN1 P18031 1/20 0.42
PTPN12 Q05209 1/20 0.42
PTPN22 Q9Y2R2 1/20 0.42
HDAC4 P56524 1/20 0.41
NR4A2 P43354 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
SPHK2 Q9NRA0 2/20 0.40
NR1H4 Q96RI1 1/20 0.40
F10 P00742 2/20 0.39
F9 P00740 1/20 0.39
DHODH Q02127 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4361498 0.90 FFAR1 (0.41) SMPD1MAOBSPHK2NR1H4HDAC6
SCHEMBL4361546 0.90 HPGD (0.49) SMPD1MAOBSPHK2HPGDTSHR
SCHEMBL4360431 0.89 BCAT1 (0.46) SMPD1MAOBMRGPRX4SPHK2HDAC6
SCHEMBL4366943 0.89 SPHK2 (0.40) ANO1SMPD1MAOBNR4A2SPHK2
SCHEMBL4540500 0.88 BCAT1 (0.49) MAOB
SCHEMBL4365917 0.86 PIM1 (0.48) MAOBMRGPRX4SPHK2
SCHEMBL4366278 0.86 CTSV (0.45) MAOBHPGD
SCHEMBL4363200 0.81 SPHK2 (0.41) SMPD1MAOBPTPN1NR4A2SPHK2
SCHEMBL4358731 0.79 MEN1 (0.57) NR1H4F10HDAC6SMN1; SMN2
SCHEMBL4366956 0.78 SMN1; SMN2 (0.48) HPGDTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US claimed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US claimed
EP-1562895-A1 SUBSTITUTED ARYL ACYLTHIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION Achillion Pharmaceuticals, Inc. (US) 2005-08-17 EP claimed
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. 2004-07-15 US claimed
WO-2004046095-A1 SUBSTITUTED ARYL THIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2004-06-03 WO claimed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7094807-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2006-08-22 US disclosed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, TPMT ANO1 3050/4885SMPD1 685/4885MAOB 1226/4885
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, SLC10A1 ANO1 3118/4885SMPD1 859/4885MAOB 886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.